Our Approach to Partnering
Collaborating with partners helps bring medical advances to patients
Sunovion Canada is interested in partnering on innovative therapies in the fields of psychiatry, neurology and infectious disease. We are a highly experienced Canadian company with a strong history of partnering for the commercialisation of products in Canada, including regulatory approval, pricing, reimbursement, marketing and sales. We remain very interested in acquiring and licencing additional products for the Canadian marketplace.
Please direct inquiries regarding collaboration and partnership opportunities for the Canadian market to:
- Lisa Mullett
General Manager
Sunovion Pharmaceuticals Canada Inc.
7025 Langer Drive
Suite 301
Mississauga, ON
L5N 0E8
Phone: 905-814-9145
Fax: 905-363-0162
Our Therapeutic Areas of Interest
Dedicating ourselves to developing advanced medical therapies
Our long-term commitment to fund innovative research and discovery and our track record of success sets us apart.
Sunovion could be the right partner to progress your idea for a new medication, breakthrough mechanism of action, or technology that may improve the lives of people with serious medical conditions.